At Washington Interventional Psychiatry (WIP), we offer ketamine-assisted psychotherapy (KAP) for PTSD, trauma-related disorders, and other mental health conditions. Serving patients throughout Washington, D.C., Maryland, and Virginia (the DMV), our model integrates psychiatric oversight with structured therapeutic work.
In addition to working with WIP-affiliated therapists, we collaborate with community therapists who wish to conduct ketamine-assisted sessions for their own patients within a medically supervised setting. All cases are evaluated and managed by WIP psychiatrists to ensure appropriate patient selection, dosing strategy, and clinical safety.
This coordinated approach allows ketamine-assisted psychotherapy to occur within comprehensive psychiatric care rather than as a standalone service.
Ketamine-assisted psychotherapy (KAP) integrates structured therapeutic work with carefully supervised ketamine treatment. At Washington Interventional Psychiatry (WIP), KAP is delivered within a comprehensive psychiatric framework rather than as a standalone service.
Research suggests that ketamine may enhance neuroplasticity and temporarily increase cognitive and emotional flexibility. For some patients, this may create a therapeutic window during which psychotherapy can more effectively address trauma-related symptoms, depression, anxiety, and other treatment-resistant conditions.
All patients undergo formal psychiatric evaluation prior to initiating ketamine-assisted psychotherapy. Treatment planning includes diagnostic formulation, review of prior treatment history, individualized dosing strategy, and safety assessment.
Ketamine-assisted sessions are conducted within a medically supervised environment, with coordination between psychiatrists and therapists. This collaborative structure ensures that medication management, therapeutic goals, and longitudinal care remain aligned.
In addition to working with WIP-affiliated therapists, we collaborate with community therapists who wish to conduct ketamine-assisted sessions for their own patients within a medically supervised setting. Psychiatric evaluation and dosing oversight remain central to every case.
This model allows psychotherapy to occur within appropriate medical parameters while preserving continuity in the patient’s existing therapeutic relationship.
Ketamine-assisted psychotherapy may be incorporated into appropriate Ketamine Treatments:
Route of administration is determined by the treating psychiatrist based on clinical indication, prior response, safety considerations, treatment goals and therapist input.
Intranasal ketamine (INH) may be considered in selected cases when clinically appropriate. Oral ketamine (troches) may also be used in carefully selected patients. Dosing is individualized and coordinated with therapeutic sessions.
Regardless of route, all ketamine treatment at WIP occurs within structured psychiatric oversight and longitudinal care.
While research continues regarding psychedelic compounds such as psilocybin and MDMA, these medications are not currently FDA-approved for routine psychiatric treatment. WIP does not offer these medications at this time.
While ketamine-assisted psychotherapy is most commonly used for mood disorders, trauma-related conditions, and treatment-resistant symptoms, some individuals seek treatment for persistent psychological patterns or distress that have not responded to traditional therapeutic approaches.
In all cases, a structured psychiatric evaluation is required to determine clinical appropriateness prior to initiating ketamine treatment.
The WIP standard of care includes:
Ketamine-Assisted Psychotherapy (KAP) begins with a comprehensive psychiatric and medical evaluation to determine clinical appropriateness.
Treatment is delivered within a structured framework that integrates psychiatric oversight with collaborative psychotherapy. Board-certified psychiatrists oversee medication strategy and safety, while trained KAP therapists guide preparation and integration.
Care is coordinated to ensure clinical clarity, safety, and therapeutic continuity throughout the process.
Ketamine-Assisted Psychotherapy (KAP) combines the neurobiological effects of ketamine with structured psychotherapy to support treatment for depression, PTSD, and other mood disorders.
During a ketamine infusion session, patients enter a temporary altered state of consciousness. Many describe this state as similar to deep meditation or a shift in perspective. Within this state, it may become easier to examine difficult emotions, trauma-related material, or long-standing thought patterns with greater psychological distance.
Common experiences during a ketamine session may include:
• A sense of detachment from habitual thought patterns
• Increased cognitive flexibility and new perspectives
• Greater emotional openness
• Access to memories or themes that are difficult to approach in traditional therapy
• At higher doses, visual or symbolic imagery
KAP is delivered within a structured psychiatric framework, with preparation and integration sessions designed to translate insights into meaningful and sustained clinical improvement.
For many patients, ketamine-assisted therapy is a new treatment option. Before beginning care, each patient undergoes a comprehensive psychiatric and medical evaluation to ensure appropriateness and safety.
Our board-certified psychiatrists and clinical team provide structured oversight throughout the treatment process.
Ketamine Assisted Psychotherapy can be beneficial for a range of conditions, including:
However, it’s not suitable for everyone. Our thorough evaluation process helps determine if ketamine assisted therapy is the right choice for your unique situation.
Ketamine-assisted psychotherapy sessions are scheduled in two-hour blocks and are priced at $500 per session. Therapist fees are billed separately and vary based on the individual therapist’s hourly rate.
KAP sessions may utilize intramuscular (IM), intravenous (IV), intranasal (INH), or oral ketamine (troche) when clinically appropriate. Route of administration is determined by the treating psychiatrist based on clinical indication and treatment structure.
Ketamine-assisted psychotherapy is typically not covered by insurance. Coverage for psychiatric evaluation or medication management may vary depending on the patient’s plan.
To learn more or determine whether KAP is appropriate for your case, please contact our office or schedule a complimentary consultation.
.
To determine whether ketamine-assisted psychotherapy is clinically appropriate for you, schedule a consultation with a WIP psychiatrist.
Our Ketamine Assisted Psychotherapy clinic is located at 4325 49th Street NW, Suite 200, Washington, D.C. 20016.
